NEW YORK (GenomeWeb) – Thermo Fisher Scientific today reported a 4 percent year-over-year increase in its fourth quarter revenues.

For the three months ended Dec. 31, 2015, Thermo Fisher said that revenues totaled $4.65 billion compared to $4.49 billion in Q4 2014 and beating the consensus Wall Street estimate of $4.55 billion.

Organic revenues grew 7 percent year over year, the company said, while acquisitions increased revenues by 1 percent. Currency translation reduced revenues by 4 percent.

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

360Dx reports that the US Centers for Medicare & Medicaid Services would cover next-generation sequencing-based cancer panel tests.

The Washington Post reports that a meteorologist is being considered as presidential science and technology advisor.

In PNAS this week: precision medicine strategy to screen for disease risk, genome evolution in Haemophilus influenzae, and more.

Researchers have developed a PCR-based assay to gauge whether manatees are present in waters.